⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNYA News
Tenaya Therapeutics, Inc. Common Stock
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
TNYA
Form 8-K
sec.gov
TNYA
Form 8-K
sec.gov
TNYA
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
globenewswire.com
TNYA
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
globenewswire.com
TNYA
Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026
globenewswire.com
TNYA
Form 8-K
sec.gov
TNYA
Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
globenewswire.com
TNYA
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
globenewswire.com
TNYA
Form 8-K
sec.gov
TNYA